# A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin

> **NCT01447797** · PHASE1 · COMPLETED · sponsor: **Hanmi Pharmaceutical Company Limited** · enrollment: 52 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** HCP0912 / Irbesartan and Atorvastatin

## Key facts

- **NCT ID:** NCT01447797
- **Lead sponsor:** Hanmi Pharmaceutical Company Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-09
- **Primary completion:** 2011-11
- **Final completion:** 2011-12
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2012-04-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01447797

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01447797, "A Bioequivalence Study Comparing Irbesartan/Atorvastatin Combination Tablet With Coadministration of Irbesartan and Atorvastatin". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01447797. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*